drugset / Trial / NCT03091894

Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy

NCT03091894 ↗

Phase 4 Completed 50 enrolled Essam Fathi
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This study evaluate the effect of adding dexmedetomidine intravenous infusion to propofol intravenous infusion during sedation for drug induced sleep endoscopy. Twenty five patients will receive propofol only while the other twenty five will receive propofol and dexmedetomidine.

Timeline

Start
2017-04-09
Primary completion
2018-04-08
Completion
2018-04-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg Intravenous
Comparator Propofol Small molecule 25 ug/kg Intravenous
Comparator Propofol Small molecule 75 ug/kg Intravenous